Skip to main content

Advertisement

Log in

Splenic leukocytes mediate the hyperglycemic exacerbation of myocardial infarct size in mice

  • Original Contribution
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Abstract

Acute hyperglycemia during acute myocardial infarction is associated with worse myocardial injury and increased mortality. Using a mouse model of myocardial ischemia/reperfusion injury, we tested the hypothesis that acute hyperglycemia activates splenic leukocytes and subsequently exacerbates myocardial infarct size. We then examined whether the adverse effects of hyperglycemia could be attenuated by a potent anti-inflammatory agent (an agonist of the adenosine A2A receptor) administered immediately prior to reperfusion. C57BL6 (WT) mice underwent 30-min LAD occlusion and 60-min reperfusion with or without prior splenectomy. Acute hyperglycemia before ischemia increased myocardial infarct size (IS) by 43 % (p < 0.05). Splenectomy before ischemia did not change IS (vs. control, p = NS) but did serve to prevent the exacerbation of IS by hyperglycemia. Acute hyperglycemia activated splenic leukocytes by increasing formyl peptide receptor expression and reactive oxygen species production before ischemia, and enhanced splenic neutrophil release with resultant peripheral neutrophilia and increased myocardial neutrophil infiltration during reperfusion. Acute adoptive transfer of splenic leukocytes to splenectomized mice before ischemia restored the hyperglycemic exacerbation of infarct size. ATL146e, an adenosine 2A receptor (A2AR) agonist, abolished neutrophilia during reperfusion and reduced IS in hyperglycemic mice. ATL146e also reduced IS in splenectomized hyperglycemic mice with transfer of WT splenic leukocytes, but not with transfer of splenic leukocytes from A2AR knockout mice. Acute hyperglycemia prior to myocardial ischemia and reperfusion exacerbates IS by activating splenic leukocytes. ATL146e administered at reperfusion suffices to abrogate the hyperglycemic exacerbation of IS by acting on A2ARs on splenic leukocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Albacker T, Carvalho G, Schricker T, Lachapelle K (2008) High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients. Ann Thorac Surg 86:20–27. doi:10.1016/j.athoracsur.2008.03.046

    Article  PubMed  Google Scholar 

  2. Bhamidipati CM, LaPar DJ, Stukenborg GJ, Morrison CC, Kern JA, Kron IL, Ailawadi G (2011) Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 141:543–551. doi:10.1016/j.jtcvs.2010.10.005

    Article  PubMed Central  PubMed  Google Scholar 

  3. Bodi V, Sanchis J, Nunez J, Rumiza E, Mainar L, Lopez-Lereu MP, Monmeneu JV, Oltra R, Forteza MJ, Chorro FJ, Llacer A (2009) Post-reperfusion lymphopenia and microvascular obstruction in ST-segment elevation acute myocardial infarction. Rev Esp Cardiol 62:1109–1117. doi:10.1016/S1885-5857(09)73325-0

    Article  PubMed  Google Scholar 

  4. Celik T (2009) Glucose-insulin-potassium infusion in the management of acute hyperglycemia in patients with ST-segment elevation acute myocardial infarction: lessons learned from randomized trials. J Cardiol 54:167–168. doi:10.1016/j.jjcc.2009.02.015 (Author reply 168)

    Article  PubMed  Google Scholar 

  5. Chakrabarti AK, Singh P, Gopalakrishnan L, Kumar V, Elizabeth Doherty M, Abueg C, Wang W, Gibson CM (2012) Admission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics. Cardiol Res Pract. doi:10.1155/2012/704314

    PubMed Central  PubMed  Google Scholar 

  6. Coquery CM, Loo W, Buszko M, Lannigan J, Erickson LD (2012) Optimized protocol for the isolation of spleen-resident murine neutrophils. Cytom A 81:806–814. doi:10.1002/cyto.a.22096

    Article  Google Scholar 

  7. Deckers JW, van Domburg RT, Akkerhuis M, Nauta ST (2013) Relation of admission glucose levels, short- and long-term (20-year) mortality after acute myocardial infarction. Am J Cardiol 112:1306–1310. doi:10.1016/j.amjcard.2013.06.007

    Article  CAS  PubMed  Google Scholar 

  8. Djordjevic-Radojkovic D, Koracevic G, Stanojevic D, Damjanovic M, Apostolovic S, Pavlovic M (2013) Stress hyperglycemia in acute ST-segment elevation myocardial infarction is a marker of left ventricular remodeling. Acute Card Care 15:38–43. doi:10.3109/17482941.2013.781190

    Article  PubMed  Google Scholar 

  9. Ekmekci A, Uluganyan M, Tufan F, Uyarel H, Karaca G, Kul S, Gungor B, Ertas G, Erer B, Sayar N, Gul M, Eren M (2013) Impact of admission blood glucose levels on prognosis of elderly patients with ST elevation myocardial infarction treated by primary percutaneous coronary intervention. J Geriatr Cardiol 10:310–316. doi:10.3969/j.issn.1671-5411.2013.04.002

    PubMed Central  PubMed  Google Scholar 

  10. Fu H, Bjorkman L, Janmey P, Karlsson A, Karlsson J, Movitz C, Dahlgren C (2004) The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide. BMC Cell Biol 5:50. doi:10.1186/1471-2121-5-50

    Article  PubMed Central  PubMed  Google Scholar 

  11. Harada N, Okajima K, Murakami K, Usune S, Sato C, Ohshima K, Katsuragi T (2000) Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation. J Pharmacol Exp Ther 294:1034–1042

    CAS  PubMed  Google Scholar 

  12. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, Umemura T, Nakamura S, Yoshida M (2003) Effect of acute hyperglycemia on the ischemic preconditioning effect of prodromal angina pectoris in patients with a first anterior wall acute myocardial infarction. Am J Cardiol 92:288–291. doi:10.1016/S0002-9149(03)00627-1

    Article  PubMed  Google Scholar 

  13. Jugdutt BI, Menon V (2002) Beneficial effects of therapy on the progression of structural remodeling during healing after reperfused and nonreperfused myocardial infarction: different effects on different parameters. J Cardiovasc Pharmacol Ther 7:95–107. doi:10.1177/107424840200700206

    Article  CAS  PubMed  Google Scholar 

  14. Jung K, Kim P, Leuschner F, Gorbatov R, Kim JK, Ueno T, Nahrendorf M, Yun SH (2013) Endoscopic time-lapse imaging of immune cells in infarcted mouse hearts. Circ Res 112:891–899. doi:10.1161/CIRCRESAHA.111.300484

    Article  CAS  PubMed  Google Scholar 

  15. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR (2002) Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology 96:183–188. doi:10.1097/00000542-200201000-00032

    Article  CAS  PubMed  Google Scholar 

  16. Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC (2000) Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol 278:H1218–H1224

    CAS  PubMed  Google Scholar 

  17. Kilpatrick EL, Narayan P, Mentzer RM Jr, Lasley RD (2002) Cardiac myocyte adenosine A2a receptor activation fails to alter cAMP or contractility: role of receptor localization. Am J Physiol Heart Circ Physiol 282:H1035–H1040. doi:10.1152/ajpheart.00808.2001

    Article  CAS  PubMed  Google Scholar 

  18. Kummer U, Zobeley J, Brasen JC, Fahmy R, Kindzelskii AL, Petty AR, Clark AJ, Petty HR (2007) Elevated glucose concentrations promote receptor-independent activation of adherent human neutrophils: an experimental and computational approach. Biophys J 92:2597–2607. doi:10.1529/biophysj.106.086769

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Leuschner F, Panizzi P, Chico-Calero I, Lee WW, Ueno T, Cortez-Retamozo V, Waterman P, Gorbatov R, Marinelli B, Iwamoto Y, Chudnovskiy A, Figueiredo JL, Sosnovik DE, Pittet MJ, Swirski FK, Weissleder R, Nahrendorf M (2010) Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res 107:1364–1373. doi:10.1161/CIRCRESAHA.110.227454

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Ma Y, Yabluchanskiy A, Lindsey ML (2013) Neutrophil roles in left ventricular remodeling following myocardial infarction. Fibrogenesis Tissue Repair 6:11. doi:10.1186/1755-1536-6-11

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Mandal P, Novotny M, Hamilton TA (2005) Lipopolysaccharide induces formyl peptide receptor 1 gene expression in macrophages and neutrophils via transcriptional and posttranscriptional mechanisms. J Immunol 175:6085–6091. doi:10.4049/jimmunol.175.9.6085

    Article  CAS  PubMed  Google Scholar 

  22. Marala RB, Mustafa SJ (1998) Immunological characterization of adenosine A2A receptors in human and porcine cardiovascular tissues. J Pharmacol Exp Ther 286:1051–1057

    CAS  PubMed  Google Scholar 

  23. Marfella R, D’Amico M, Di Filippo C, Piegari E, Nappo F, Esposito K, Berrino L, Rossi F, Giugliano D (2002) Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia 45:1172–1181. doi:10.1007/s00125-002-0882-x

    Article  CAS  PubMed  Google Scholar 

  24. Marfella R, Di Filippo C, Portoghese M, Ferraraccio F, Rizzo MR, Siniscalchi M, Musacchio E, D’Amico M, Rossi F, Paolisso G (2009) Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. J Am Coll Cardiol 53:1425–1436. doi:10.1016/j.jacc.2009.01.041

    Article  CAS  PubMed  Google Scholar 

  25. Marfella R, Siniscalchi M, Esposito K, Sellitto A, De Fanis U, Romano C, Portoghese M, Siciliano S, Nappo F, Sasso FC, Mininni N, Cacciapuoti F, Lucivero G, Giunta R, Verza M, Giugliano D (2003) Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 26:3129–3135. doi:10.2337/diacare.26.11.3129

    Article  PubMed  Google Scholar 

  26. Matyal R, Sakamuri S, Huang T, Owais K, Parikh S, Khabbaz K, Wang A, Sellke F, Mahmood F (2014) Oxidative stress and nerve function after cardiopulmonary bypass in patients with diabetes. Ann Thorac Surg. doi:10.1016/j.athoracsur.2014.06.041

    Google Scholar 

  27. Myant KB, Cammareri P, McGhee EJ, Ridgway RA, Huels DJ, Cordero JB, Schwitalla S, Kalna G, Ogg EL, Athineos D, Timpson P, Vidal M, Murray GI, Greten FR, Anderson KI, Sansom OJ (2013) ROS production and NF-kappaB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell 12:761–773. doi:10.1016/j.stem.2013.04.006

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Ohta A, Sitkovsky M (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414:916–920. doi:10.1038/414916a

    Article  CAS  PubMed  Google Scholar 

  29. Panaro MA, Acquafredda A, Sisto M, Lisi S, Maffione AB, Mitolo V (2006) Biological role of the N-formyl peptide receptors. Immunopharmacol Immunotoxicol 28:103–127. doi:10.1080/08923970600625975

    Article  CAS  PubMed  Google Scholar 

  30. Pesaro AE, Nicolau JC, Serrano CV Jr, Truffa R, Gaz MV, Karbstein R, Giraldez RR, Kalil Filho R, Ramires JA (2009) Influence of leukocytes and glycemia on the prognosis of patients with acute myocardial infarction. Arq Bras Cardiol 92:84–93

    Article  PubMed  Google Scholar 

  31. Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M, Comerma L, Chorny A, Shan M, Xu W, Magri G, Knowles DM, Tam W, Chiu A, Bussel JB, Serrano S, Lorente JA, Bellosillo B, Lloreta J, Juanpere N, Alameda F, Baro T, de Heredia CD, Toran N, Catala A, Torrebadell M, Fortuny C, Cusi V, Carreras C, Diaz GA, Blander JM, Farber CM, Silvestri G, Cunningham-Rundles C, Calvillo M, Dufour C, Notarangelo LD, Lougaris V, Plebani A, Casanova JL, Ganal SC, Diefenbach A, Arostegui JI, Juan M, Yague J, Mahlaoui N, Donadieu J, Chen K, Cerutti A (2012) B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol 13:170–180. doi:10.1038/ni.2194

    Article  CAS  Google Scholar 

  32. Raiden S, Nahmod K, Nahmod V, Semeniuk G, Pereira Y, Alvarez C, Giordano M, Geffner JR (2002) Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome. J Pharmacol Exp Ther 303:45–51. doi:10.1124/jpet.102.037382

    Article  CAS  PubMed  Google Scholar 

  33. Save S, Mohlin C, Vumma R, Persson K (2011) Activation of adenosine A2A receptors inhibits neutrophil transuroepithelial migration. Infect Immun 79:3431–3437. doi:10.1128/IAI.05005-11

    Article  PubMed Central  PubMed  Google Scholar 

  34. Schofield ZV, Woodruff TM, Halai R, Wu MC, Cooper MA (2013) Neutrophils—a key component of ischemia-reperfusion injury. Shock 40:463–470. doi:10.1097/SHK.0000000000000044

    Article  CAS  PubMed  Google Scholar 

  35. Shay T, Jojic V, Zuk O, Rothamel K, Puyraimond-Zemmour D, Feng T, Wakamatsu E, Benoist C, Koller D, Regev A, ImmGen C (2013) Conservation and divergence in the transcriptional programs of the human and mouse immune systems. Proc Natl Acad Sci USA 110:2946–2951. doi:10.1073/pnas.1222738110

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Shore S, Borgerding JA, Gylys-Colwell I, McDermott K, Ho PM, Tillquist MN, Lowy E, McGuire DK, Stolker JM, Arnold SV, Kosiborod M, Maddox TM (2014) Association between hyperglycemia at admission during hospitalization for acute myocardial infarction and subsequent diabetes: insights From the Veterans Administration Cardiac Care Follow-up Clinical Study. Diabetes Care 37:409–418. doi:10.2337/dc13-1125

    Article  PubMed  Google Scholar 

  37. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo JL, Kohler RH, Chudnovskiy A, Waterman P, Aikawa E, Mempel TR, Libby P, Weissleder R, Pittet MJ (2009) Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325:612–616. doi:10.1126/science.1175202

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Szekely A, Levin J, Miao Y, Tudor IC, Vuylsteke A, Ofner P, Mangano DT, Investigators of the Multicenter Study of Perioperative Ischemia Research G, the Ischemia R, Education F (2011) Impact of hyperglycemia on perioperative mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 142:430–437. doi:10.1016/j.jtcvs.2011.03.009

    Article  PubMed  Google Scholar 

  39. Teraguchi I, Imanishi T, Ozaki Y, Tanimoto T, Kitabata H, Ino Y, Ishibashi K, Komukai K, Hirata K, Akasaka T (2012) Impact of stress hyperglycemia on myocardial salvage following successfully recanalized primary acute myocardial infarction. Circ J 76:2690–2696. doi:10.1253/circj.CJ-12-0303

    Article  PubMed  Google Scholar 

  40. Terlecki M, Bednarek A, Kawecka-Jaszcz K, Czarnecka D, Bryniarski L (2013) Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction. Kardiol Pol 71:260–267. doi:10.5603/KP.2013.0038

    Article  PubMed  Google Scholar 

  41. Vandervelde S, van Amerongen MJ, Tio RA, Petersen AH, van Luyn MJ, Harmsen MC (2006) Increased inflammatory response and neovascularization in reperfused vs. non-reperfused murine myocardial infarction. Cardiovasc Pathol 15:83–90. doi:10.1016/j.carpath.2005.10.006

    Article  PubMed  Google Scholar 

  42. Varani K, Gessi S, Dionisotti S, Ongini E, Borea PA (1998) [3H]-SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes. Br J Pharmacol 123:1723–1731. doi:10.1038/sj.bjp.0701758

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL (2002) Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 40:1748–1754. doi:10.1016/S0735-1097(02)02483-X

    Article  CAS  PubMed  Google Scholar 

  44. Walker EF (1999) Management of diabetes and hyperglycaemia during myocardial infarction: review of the literature. Intensive Crit Care Nurs 15:259–265. doi:10.1054/iccn.1999.1461

    Article  CAS  PubMed  Google Scholar 

  45. Wang Z, Ni J, Shao D, Liu J, Shen Y, Zhou L, Huang Y, Yu C, Wang J, Xue H, Lu L (2013) Elevated transcriptional co-activator p102 mediates angiotensin II type 1 receptor up-regulation and extracellular matrix overproduction in the high glucose-treated rat glomerular mesangial cells and isolated glomeruli. Eur J Pharmacol 702:208–217. doi:10.1016/j.ejphar.2013.01.031

    Article  CAS  PubMed  Google Scholar 

  46. Yang Z, Day YJ, Toufektsian MC, Xu Y, Ramos SI, Marshall MA, French BA, Linden J (2006) Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation 114:2056–2064. doi:10.1161/CIRCULATIONAHA.106.649244

    Article  CAS  PubMed  Google Scholar 

  47. Yang Z, Laubach VE, French BA, Kron IL (2009) Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion. J Thorac Cardiovasc Surg 137:723–729. doi:10.1016/j.jtcvs.2008.08.056

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Yang Z, Linden J, Berr SS, Kron IL, Beller GA, French BA (2008) Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRI. Am J Physiol Heart Circ Physiol 295:H2328–H2335. doi:10.1152/ajpheart.00091.2008

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Yang Z, Tian Y, Liu Y, Hennessy S, Kron IL, French BA (2013) Acute hyperglycemia abolishes ischemic preconditioning by inhibiting Akt phosphorylation: normalizing blood glucose before ischemia restores ischemic preconditioning. Oxid Med Cell Longev. doi:10.1155/2013/329183

    Google Scholar 

Download references

Acknowledgments

This study was funded in part by University of Virginia Department of Surgery Startup Funds and University of Virginia School of Medicine Collaborative Science Pilot Grant to ZY and by NIH R01 HL 092305 to ILK and BAF.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zequan Yang.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PPTX 10641 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tian, Y., French, B.A., Kron, I.L. et al. Splenic leukocytes mediate the hyperglycemic exacerbation of myocardial infarct size in mice. Basic Res Cardiol 110, 39 (2015). https://doi.org/10.1007/s00395-015-0496-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00395-015-0496-3

Keywords

Navigation